Literature DB >> 17955364

Treatment of depression in patients with congestive heart failure.

Peter A Shapiro1.   

Abstract

Heart failure is common, and depression is common in heart failure patients, adding substantially to the burden of the disease. There is some evidence for the safe and at least modestly effective use of psychotherapy and antidepressants to treat depression in heart failure patients. Cognitive behavioral psychotherapy and selective serotonin reuptake inhibitors are first line treatments. The efficacy of depression treatment in altering cardiac outcomes in heart failure patients has yet to be established.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17955364     DOI： 10.1007/s10741-007-9058-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  39 in total

Review 1.  Electroconvulsive therapy in patients with heart failure or valvular heart disease.

Authors:  B K Rayburn
Journal:  Convuls Ther       Date:  1997-09

2.  ADHD drugs and cardiovascular risk.

Authors:  Steven E Nissen
Journal:  N Engl J Med       Date:  2006-03-20       Impact factor: 91.245

3.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

4.  The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.

Authors:  A H Glassman; S P Roose; J T Bigger
Journal:  JAMA       Date:  1993-05-26       Impact factor: 56.272

5.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

6.  Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.

Authors:  Timothy E Wilens; Paul G Hammerness; Joseph Biederman; Anne Kwon; Thomas J Spencer; Sarah Clark; Megan Scott; Amy Podolski; Jeffrey W Ditterline; Matthew C Morris; Hadley Moore
Journal:  J Clin Psychiatry       Date:  2005-02       Impact factor: 4.384

7.  Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure.

Authors:  R Faris; H Purcell; M Y Henein; A J S Coats
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

8.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

9.  Cardiovascular effects of bupropion in depressed patients with heart disease.

Authors:  S P Roose; G W Dalack; A H Glassman; S Woodring; B T Walsh; E G Giardina
Journal:  Am J Psychiatry       Date:  1991-04       Impact factor: 18.112

10.  Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin.

Authors:  V L Serebruany; A H Glassman; A I Malinin; D Atar; D C Sane; B R Oshrine; J J Ferguson; C M O'Connor
Journal:  Eur J Heart Fail       Date:  2003-08       Impact factor: 15.534
View more
  8 in total

Review 1.  Depression after myocardial infarction.

Authors:  Melvin R Echols; Christopher M O'Connor
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 2.  Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.

Authors:  James K Rustad; Theodore A Stern; Kathy A Hebert; Dominique L Musselman
Journal:  Prim Care Companion CNS Disord       Date:  2013-08-15

Review 3.  Symptom management challenges in heart failure: pharmacotherapy considerations.

Authors:  Diana Stewart; Mary Lynn McPherson
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

4.  Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases.

Authors:  Lourdes Vicent; Juan Manuel Nuñez Olarte; Luis Puente-Maestu; Alicia Oliva; Juan Carlos López; Andrea Postigo; Irene Martín; Raquel Luna; Francisco Fernández-Avilés; Manuel Martínez-Sellés
Journal:  BMC Palliat Care       Date:  2017-05-22       Impact factor: 3.234

5.  Brief report: Characteristics of antidepressant use in patients with heart failure.

Authors:  Paul J Mills; Joel E Dimsdale; Suzi Hong; Geoffrey Van Den Brande; Laura Redwine; Barry H Greenberg; Thomas Rutledge
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

6.  Depression in patients with cardiovascular disease.

Authors:  Dimos Mastrogiannis; Gregory Giamouzis; Efthimios Dardiotis; George Karayannis; Artemis Chroub-Papavaiou; Dimitra Kremeti; Kyriakos Spiliopoulos; Panagiotis Georgoulias; Stelios Koutsias; Konstantinos Bonotis; Marianna Mantzorou; John Skoularigis; Georgios M Hadjigeorgiou; Javed Butler; Filippos Triposkiadis
Journal:  Cardiol Res Pract       Date:  2012-07-05       Impact factor: 1.866

7.  Reduction of psycho-spiritual distress of an elderly with advanced congestive heart failure by life review interview in a palliative care day center.

Authors:  Kwok-Ying Chan; Vikki Wai-Kee Lau; Ka-Chi Cheung; Richard Shek-Kwan Chang; Man-Lui Chan
Journal:  SAGE Open Med Case Rep       Date:  2016-08-26

Review 8.  Prioritizing symptom management in the treatment of chronic heart failure.

Authors:  Aaron O Koshy; Elisha R Gallivan; Melanie McGinlay; Sam Straw; Michael Drozd; Anet G Toms; John Gierula; Richard M Cubbon; Mark T Kearney; Klaus K Witte
Journal:  ESC Heart Fail       Date:  2020-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.